California’s enforcement actions against Carbon Health and Aspen Dental may signal increasing scrutiny of investor-backed healthcare arrangements nationwide.
California Attorney General Rob Bonta recently sued Carbon Health and Aspen Dental, alleging that non-physicians exercised excessive control over healthcare practices in violation of California’s corporate practice of medicine and dentistry laws. The lawsuits challenge one of the foundational structures commonly used by investors and management companies to participate in healthcare organizations. The cases resulted in more than $6 million in penalties, restitution, and operational restrictions and may represent one of the most significant challenges to management services organizations (MSOs), private equity-backed healthcare arrangements, and investor influence over healthcare delivery in recent years.
While the lawsuits arose under California law, the issues raised by these cases extend far beyond a single state. Combined with the Office of Inspector General’s recent Request for Information (RFI) concerning private equity in healthcare, increased U.S. Department of Justice scrutiny of investor-backed healthcare arrangements, and growing legislative interest in healthcare consolidation, the cases may signal the beginning of broader government examination of who controls healthcare organizations and how that control affects physician independence and patient care.
Why This Matters
Private equity firms, venture capital investors, and healthcare management companies have invested billions of dollars into physician practices, dental organizations, urgent care centers, ambulatory surgery centers, laboratories, pharmacies, home health agencies, and other healthcare businesses. Much of this investment has relied on management services organization (MSO) structures in which physicians own the professional practice while a separate management company provides administrative, operational, financial, and business support services.
These arrangements have become increasingly common across the healthcare industry because they provide access to capital, operational expertise, technology, and economies of scale. However, they also raise recurring questions regarding physician independence, corporate practice of medicine restrictions, financial incentives, and the extent to which non-physicians may influence healthcare delivery.
What California Challenged
According to the lawsuits, California alleged that non-physician entities exercised excessive influence over physician-owned healthcare practices through arrangements involving physician hiring and compensation, staffing decisions, management fees, advertising, payer negotiations, ownership rights, and other operational functions traditionally associated with professional independence.
The state’s position was not limited to who owned the practice on paper. Rather, the lawsuits focused on who exercised practical authority over the organization and whether non-physicians possessed the ability to influence decisions that should remain under the control of licensed healthcare professionals. The resulting settlements imposed significant financial penalties and operational restrictions designed to increase physician control over healthcare practices and limit the authority of affiliated management organizations.
Why Healthcare Organizations Should Pay Attention
The significance of these cases extends beyond California and beyond corporate practice of medicine laws. Federal and state authorities are increasingly examining private equity investment, healthcare consolidation, investor influence, utilization incentives, and financial arrangements that may affect medical judgment and patient care. The OIG’s recent RFI specifically sought information regarding private equity investment and healthcare transactions.
At the same time, the U.S. Department of Justice has continued pursuing enforcement actions involving investor-backed healthcare organizations, telehealth arrangements, laboratories, pharmacies, and other healthcare businesses. State attorneys general have likewise shown increasing willingness to challenge healthcare business models they believe may place financial interests ahead of patient care. Although different agencies may rely on different legal theories, the underlying question is often the same: Who controls the healthcare organization and how does that control affect physician independence, patient care, healthcare costs, and utilization of services?
Key Takeaway
Physicians, healthcare organizations, management companies, and investors should review existing management agreements, governance structures, compensation arrangements, staffing models, ownership provisions, and operational controls. The Carbon Health and Aspen Dental cases suggest that government scrutiny is increasingly focused not only on who owns a healthcare practice, but also on who exercises practical authority over the organization.
These California cases may ultimately be remembered as more than isolated enforcement actions. Combined with the OIG’s recent RFI and increasing DOJ scrutiny of investor-backed healthcare arrangements, they may represent an early indication of how federal and state authorities will evaluate MSOs, private equity-backed healthcare arrangements, and investor influence over healthcare delivery in the years ahead.
This publication is intended for general informational purposes only and does not constitute legal advice or a solicitation to provide legal services. The information in this publication is not intended to create, and receipt of it does not constitute, a lawyer-client relationship. Readers should not act upon this information without seeking professional legal counsel. The views and opinions expressed herein represent those of the individual author(s) only and are not necessarily the views of Clark Hill PLC or Clark Hill Solicitors LLP. Although we attempt to ensure that postings on our website are complete, accurate, and up to date, we assume no responsibility for their completeness, accuracy, or timeliness.
